Results

Total Results: 2,890 records

Showing results for "disease".

361. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - None of these approaches halts disease progression. … exacerbations, which may slow disease progression. … Chronic obstructive pulmonary disease (COPD) fact sheet. [internet]. … /lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html http://www.lung.org/lung-disease/copd … Chronic obstructive pulmonary disease (COPD) fact sheet. [internet].

362. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
     January 01, 2011 - Diabetes Rate in Enrolled Population Total All 2006 32.8 8.7 26.4% Age Disabled/end stage renal disease … Alaska Native 2006 0.1 0.1 36.0% Total All 2007 32.3 8.8 27.3% Age Disabled/end stage renal disease … Alaska Native 2007 0.2 0.1 37.3% Total All 2008 31.9 8.9 27.9% Age Disabled/end stage renal disease … Alaska Native 2006 9.7% 28.4% 6.4% Total All 2007 8.1% 18.9% 5.0% Age Disabled/end stage renal disease … Without Diabetes and Without PAD Total All 2006 3.3% 11.0% 2.5% Age Disabled/end stage renal disease

363. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-differ
     January 20, 2011 - Peripheral Artery Disease (PAD) defined as peripheral artery disease of the lower extremities Does … (For example, an ethnic group, stage or severity of a disease.) … Bleeding risks associated with anti-platelet therapy in patients with PAD and co-morbid disease Appropriateness … (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease, including … the Effective Health Care Program Treatment Strategies for Patients With Peripheral Artery Disease

364. Disposition of Comments Report for Comparative Effectiveness Review No. 131 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
     February 25, 2014 - Studies that compared Crohn’s disease patients to patients without inflammatory bowel disease were … instrument for adult patients with inflammatory bowel disease. … Public: UCB Results, KQ2 Crohn’s disease is a chronic inflammatory bowel disease with a relapsing and … Smith, MD Abbreviations CDAI = Crohn’s disease activity index IBD = inflammatory bowel disease Thank … The incidence/prevalence is much smaller than other chronic diseases such as rheumatoid arthritis.

365. A Review of Quality of Care Evaluation for the Palliation of Dyspnea | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dyspnea/research
     June 16, 2010 - requires valid, reliable, and responsive measures of the care provided to patients across settings and diseases … review of over 5000 titles in Western literature for quality measures of symptom management across diseases … care measure set. 17 The dyspnea measure evaluates the proportion of patients with advanced chronic diseases … VAS were felt by panelists to be appropriate for clinical dyspnea assessment in chronic progressive diseases … Descriptors of breathlessness in cardiorespiratory diseases.

366. Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-222-health-equity-preventive-services-comments.pdf
     December 03, 2019 - Correct, the scope of the review is limited to 10 preventive services for cancer, cardiovascular disease … backgrounds are receiving evidence- based preventive services for individuals with cardiovascular diseases … Julia Charles: Centers for Disease Control and Prevention In particular, subject matter experts … members of these populations to quit smoking and thereby reduce their risk of developing smoking-related diseases … Julia Charles: Centers for Disease Control and Prevention Including studies and related analyses

367. Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
     December 03, 2019 - Correct, the scope of the review is limited to 10 preventive services for cancer, cardiovascular disease … backgrounds are receiving evidence- based preventive services for individuals with cardiovascular diseases … Julia Charles: Centers for Disease Control and Prevention In particular, subject matter experts … members of these populations to quit smoking and thereby reduce their risk of developing smoking-related diseases … Julia Charles: Centers for Disease Control and Prevention Including studies and related analyses

368. Multiple-Sclerosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
     April 01, 2015 - Analytic framework for discontinuing disease-modifying treatments for MS DMT = disease-modifying treatment … and disease activity after interrupting treatment. … stages of the disease, when the side effects are less than disease symptoms. … course to prevent or delay disease progression. … We cannot currently predict early or benign disease courses.

369. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
     January 01, 2011 - Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease … Alaska Native 2006 6.9% 17.9% 5.0% Total All 2007 6.0% 13.2% 4.0% Age Disabled/end stage renal disease … Alaska Native 2007 6.8% 17.5% 4.9% Total All 2008 6.0% 13.1% 3.9% Age Disabled/end stage renal disease … With Diabetes and Without PAD Total All 2006 0.5% 2.1% 0.053% Age Disabled/end stage renal disease … 2.08% 2.07% 1.93% 1.55% Total All 2008 1.70% 1.78% 1.70% 1.43% Age† Disabled/end stage renal disease

370. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
     December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease patients using theophylline. … disease (PUD), gastroesophogeal reflux disease (GERD), arrhythmias, depression, hypertension, ischemic … A 4-year trial of tiotropium in chronic obstructive pulmonary disease. … The use of theophylline in chronic obstructive pulmonary disease. … Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.

371. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
     December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease patients using theophylline. … disease (PUD), gastroesophogeal reflux disease (GERD), arrhythmias, depression, hypertension, ischemic … A 4-year trial of tiotropium in chronic obstructive pulmonary disease. … The use of theophylline in chronic obstructive pulmonary disease. … Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.

372. Key Questions: Treatment of Stage I-III Squamous Cell Carcinoma (SCC) of the Anal Canal (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-key-questions.pdf
     January 01, 2018 - Background Anal cancer is a disease in which malignant cells form in the tissues of the anus and … KQ5) Other treatments (KQ5) (All KQs) (All KQs) Health outcomes  Overall survival  Disease-free … Fractionation schemes Outcomes Overall survival Disease-free survival Colostomy-free survival Local … Other dose de-escalation Outcomes Overall survival Disease-free survival Colostomy-free survival … Mayo Clinic. doi: https://www.mayoclinic.org/diseases-conditions/anal- cancer/diagnosis-treatment/drc

373. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
     August 01, 2012 - monitoring.8,11 The SFLC assay may also be the only means of detecting a disease marker in some disease … disease settings, and their results need to be evaluated with this in mind. … as well as different disease populations. … Finally, variation in disease severity studied can lead to spectrum bias. … of disease (e.g., response to treatment, relapse, or light chain escape).

374. Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
     August 01, 2012 - increased dramatically from 2002 to 2007 for both women with DCIS (<1% to 12.9%) and with invasive disease … Specifically, we included International Classification of Diseases for Oncology, Third Edition (ICD-O … Among women with invasive cancer, rates of MRI use de- creased with higher grade disease. … The increase was observed for both women with DCIS and early invasive disease. … ) received more MRIs prior to surgery than those with lower risk disease.

375. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
     January 01, 2008 - HSCTs are used to treat both malignant and non-malignant diseases in children. … HSCT is associated with high morbidity and mortality in all ages and all diseases. … Factors that impact the appropriateness and success of any HSCT include the stage and/or severity of the disease … ), there is a large body of literature regarding HSCT across many diseases. … The diseases covered in the AHRQ review will be defined during the refinement phase.

376. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
     December 01, 2023 - The Office of Disease Prevention anticipated that the risk of postpartum maternal morbidity and mortality … stemmed from the fact that a number of states have added violence- related questions to the Center for Disease … percent by comorbidities (including prepregnancy body mass index, diabetes, hypertension, cardiac disease … , renal disease, pulmonary disease, musculoskeletal disease, blood disorders, mental disorders, … 4 central nervous system disorders, rheumatic heart disease, anemia, and asthma).6 Finally, if rural

377. Infection Prevention and Control for the Emergency Medical Services/911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/ems-911-workforce-technical-brief_0.pdf
     March 10, 2022 - the beginning of the coronavirus disease 2019 (COVID-19) pandemic … EMS Infectious Disease Playbook U.S. … Centers for Disease Control and Prevention; 2020. … Centers for Disease Control and Prevention. … Centers for Disease Control and Prevention; 2016.

378. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
     August 01, 2024 - doublet chemoradiation (CRT) with 5-fluorouracil (5FU) plus mitomycin (MMC) likely results in greater disease-free … • Compared with concurrent CRT with 5FU, CRT with 5FU plus MMC may result in greater disease-free … with capecitabine plus MMC, CRT with paclitaxel plus capecitabine plus MMC showed greater overall, disease … Moderate Disease-specific mortality (up to 5 yrs) 1; RCT; n=585 CRT favored over RT alone; rate … Low Disease-free survival (up to 3 yrs) 1; RCT; n=144 Significantly greater in the paclitaxel arm

379. Ch 6-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
     October 30, 2012 - such as in cancer or H5N1 influenza; or to manage or reduce the burden of chronic diseases including … diabetes, psoriasis, Parkinson’s disease, and depression. … only six items.34 In contrast, other popular measures focus on symptoms that are affected by many diseases … Statistical validation of intermediate endpoints for chronic diseases. … The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal

380. Restless-Legs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
     December 16, 2011 - and Objectives for the Systematic Review Overview Restless legs syndrome (RLS) or Willis-Ekbom disease … If the disease progresses, symptoms may occur earlier in the day and intensify even further at night … used to assess disease severity and treatment- induced changes in disease status. … Yet, the disease is chronic, often requiring life-long treatment. … and definition of clinically significant change in disease status used in individual studies.